Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Isis now fully owns fomivirsen

Aug. 23, 1996

Solvay to copromote Famvir in U.S.

Aug. 23, 1996

Sequus and Torrex Pharma sign Amphotec marketing agreement

Aug. 23, 1996

Xoma granted permission to commence phase III for rBPI21

Aug. 23, 1996

Parke-Davis and Xenova begin evaluation of novel antibacterial

Aug. 23, 1996

Takeda describes cephem antibacterial agents

Aug. 23, 1996

HHV-8 implicated in KS development

Aug. 16, 1996

Lidak initiates further trials of Lidakol in oral herpes

Aug. 16, 1996

Hybridon prepares for GEM-132 clinical testing

Aug. 16, 1996

FDA approves generic clotrimazole

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 31, 2025
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...
Novo weight-loss data roll out; Veru ‘leans’ in
BioWorld
As investors look ahead to data shortly from Veru Inc. with enobosarm, the weight-loss space remains hot, with Novo Nordisk A/S reporting favorable top-line...
Appointments and advancements for Jan. 29, 2025
BioWorld
New hires and promotions in the biopharma industry, including: Allogene, Alumis, Beximco, Clarametyx, Commit, Concerto, OS Therapies, Precision, Roche, Scholar Rock.